Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 5/20 | 0.39 |
| ▸ | ANPEP | P15144 | 2/20 | 0.38 |
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.34 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.31 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2576303 | 0.98 | ENPEP (0.38) | ENPEPANPEPGSTK1KMT2AALOX15 | |
| SCHEMBL3277681 | 0.88 | TP53 (0.33) | ENPEPANPEPGSTK1KMT2AMEN1 | |
| SCHEMBL3277556 | 0.86 | TP53 (0.33) | ENPEPANPEPKMT2AMEN1FAAH | |
| SCHEMBL3338585 | 0.86 | TP53 (0.33) | ENPEPANPEPKMT2AMEN1FAAH | |
| SCHEMBL3278910 | 0.86 | TP53 (0.33) | ENPEPANPEPKMT2AMEN1FAAH | |
| Hexanoate SCHEMBL3278765 | 0.85 | FFAR4 (0.51) | ENPEPKMT2AALOX15MEN1 | |
| Dihydrolipoic Acid SCHEMBL867951 | 0.83 | FOLH1 (0.56) | ENPEPANPEPGSTK1PMP22FOLH1 | |
| Dihydrolipoic Acid SCHEMBL1115003 | 0.83 | FOLH1 (0.56) | ENPEPANPEPGSTK1PMP22FOLH1 | |
| Dihydrolipoic Acid SCHEMBL618576 | 0.83 | FOLH1 (0.56) | ENPEPANPEPGSTK1PMP22FOLH1 | |
| Dihydrolipoic Acid SCHEMBL19773 | 0.83 | FOLH1 (0.56) | ENPEPANPEPGSTK1PMP22FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1474 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116536229-B | Strain for producing lactic acid monomer by utilizing glycerol and application thereof | 天津科技大学 | 2025-03-11 | — | — | CN | claimed |
| EP-4092115-B1 | NOVEL DIHYDROLIPOAMIDE ACETYLTRANSFERASE VARIANT AND METHOD FOR PRODUCING L-VALINE USING SAME | CJ CHEILJEDANG CORP (KR) | 2024-07-03 | — | — | EP | claimed |
| EP-3368070-B9 | NEOSPORA VACCINE COMPOSITION | UNIV MADRID COMPLUTENSE (ES) | 2023-10-18 | — | — | EP | claimed |
| CN-116478953-B | Acinetobacter baumannii DlaT recombinant protein, preparation method and application | 四川大学华西医院 | 2023-09-12 | — | — | CN | claimed |
| EP-3368070-B1 | NEOSPORA VACCINE COMPOSITION | UNIV MADRID COMPLUTENSE (ES) | 2023-08-30 | — | — | EP | claimed |
| CN-116590207-A | Strain for producing lactic acid monomer by utilizing glucose and application thereof | 天津科技大学 | 2023-08-15 | — | — | CN | claimed |
| CN-115485373-B | New dihydrolipoamide acetyltransferase variants and method for producing L-valine using the same | CJ第一制糖株式会社 | 2023-08-11 | — | — | CN | claimed |
| CN-116536229-A | Strain for producing lactic acid monomer by utilizing glycerol and application thereof | 天津科技大学 | 2023-08-04 | — | — | CN | claimed |
| CN-116478953-A | Acinetobacter baumannii DlaT recombinant protein, preparation method and application | 四川大学华西医院 | 2023-07-25 | — | — | CN | claimed |
| CN-115917324-A | Methods of treating cancer | 布罗德研究所有限公司 | 2023-04-04 | — | — | CN | claimed |
| US-5965618-A | Treatment of scar tissue using lipoic acid | THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY, AS ADMINISTRATIVE AGENT | 1999-10-12 | — | — | US | claimed |
| WO-1999025330-A1 | TREATMENT OF SCAR TISSUE USING LIPOIC ACID | PERRICONE NICHOLAS V (US) | 1999-05-27 | — | — | WO | claimed |
| WO-1998041213-A1 | COMPOSITIONS CONTAINING LYSOPHOSPHOTIDIC ACIDS WHICH INHIBIT APOPTOSIS AND USES THEREOF | LXR BIOTECHNOLOGY INC. (US) | 1998-09-24 | — | — | WO | claimed |
| EP-0472658-A4 | FUSION PROTEINS HAVING AN IN VIVO POST-TRANSLATIONAL MODIFICATION SITE AND METHODS OF MANUFACTURE AND PURIFICATION | BIOTECHNOLOGY RES & DEV (US) | 1992-08-26 | — | — | EP | claimed |
| EP-0472658-A1 | FUSION PROTEINS HAVING AN IN VIVO POST-TRANSLATIONAL MODIFICATION SITE AND METHODS OF MANUFACTURE AND PURIFICATION | BIOTECHNOLOGY RESEARCH AND DEVELOPMENT CORPORATION INCORPORATED (US) | 1992-03-04 | — | — | EP | claimed |
| EP-0159870-B1 | METHOD FOR THE DETERMINATION OF MERCAPTO COMPOUNDS AND REAGENT FOR USE THEREIN | Kyowa Medex Co. Ltd. (JP) | 1992-02-12 | — | — | EP | claimed |
| US-4978615-A | REACTING WITH CHROMOGEN TO PRODUCE MEASURABLE PIGMENT | KYOWA MEDEX CO., LTD. (JP) | 1990-12-18 | — | — | US | claimed |
| WO-1990014431-A1 | FUSION PROTEINS HAVING AN IN VIVO POST-TRANSLATIONAL MODIFICATION SITE AND METHODS OF MANUFACTURE AND PURIFICATION | BIOTECHNOLOGY RESEARCH AND DEVELOPMENT CORPORATION (US) | 1990-11-29 | — | — | WO | claimed |
| EP-0159870-A2 | Method for the determination of mercapto compounds and reagent for use therein | Kyowa Medex Co. Ltd. (JP) | 1985-10-30 | — | — | EP | claimed |
| US-4272503-A | FORMING A STABLE COMPLEX OF LIGAND AND TECHNETIUM BY THE REDUCTION OF PERTECHNETATE BY A SUBSTRATE-CHELATE-REDUCING AGENT COMPLEX; LABELS; RADIOLOGY | NEW ENGLAND NUCLEAR CORPORATION (US) | 1981-06-09 | — | — | US | claimed |